Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis

This study is testing the safety and how well a treatment called Umbilical Cord Wharton's Jelly Allograft works for people with knee osteoarthritis. This treatment involves injecting a biologic (a substance made from living organisms) directly into your knee joint. The study is looking at different doses of this injection – low, medium, and high. You might be able to join if you are over 30, have been diagnosed with moderate knee osteoarthritis (Grade II or III), have a Body Mass Index (BMI) under 50, and experience knee pain. The study will measure C-reactive protein (a marker of inflammation), erythrocyte sedimentation rate (another inflammation marker), and alanine transaminase (an enzyme that can indicate liver health) to see the treatment's effects. This is a pilot study, meaning it's an early step to see if the treatment is safe and practical.

Study design
This is a randomized, open-label pilot study with 120 participants. Participants will be assigned to one of three groups receiving different doses of the injection.
What's involved
Participants will receive one intra-articular knee injection. You will have follow-up visits and tests at baseline, 1 week, 6 weeks, 3 months, 6 months, and one year after the procedure.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for one year after the procedure to evaluate safety, pain relief, and functional improvements.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06608134

Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee Osteoarthritis

Recruiting
EARLY_PHASE1Ages 30+InterventionalTreatment
R3 Medical Research
~120 participants
Updated 2024-09-23 on ClinicalTrials.gov
What's tested:Umbilical Cord Wharton's Jelly Allograft Intra-articular Knee Injection

At a glance

Recruiting sites
5 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
C Reactive Protein
Measured over Baseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year
+7 more outcomes measured
Osteoarthritis, Knee

NCT06608134

Where you'd take part

This study runs at 5 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Dr. Duc (Steve) Le, MD

    Cleveland, Texasstudy coordinator listed

    Recruiting

  • Optimal Medical Group

    Fresno, Californiastudy coordinator listed

    Recruiting

  • R3 Anti Aging Beverly Hills

    Beverly Hills, Californiastudy coordinator listed

    Recruiting

  • R3 Anti Aging Scottsdale

    Scottsdale, Arizonastudy coordinator listed

    Recruiting

  • Scheer Medical Wellness

    New York, New Yorkstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Be over age 30
Diagnosed with Grade II or III OA on the KL scale (in one knee).
Body Mass Index (BMI) \<50Kg/m2
Pain score of 4 or more on the Numeric Pain Rating Scale (NPRS)
Female patients must be abstinent, surgically sterilized or postmenopausal
Premenopausal females must have a negative pregnancy test, on contraceptive measures and do not anticipate pregnancy during the duration of the study.
Be willing and capable of giving written informed consent to participate in English.
Be willing and capable of complying with study-related requirements, procedures and visits in English.

Exclusion

Have taken any pain medication including nonsteroidal anti-inflammatory drugs (NSAIDs) within 2 weeks prior to study injection date.
Use anticoagulants have a substance abuse history and fail to agree not to take any knee-symptom modifying drugs during the course of the study without discussing and reporting the use to the site principal investigator and study team.
Have had an intra-articular injection of any drug including viscosupplementation in the index knee in the past 6 months.
Have had surgery on the index knee with the past 6 months.
Had a traumatic injury to the index knee with the past 3 months.
Planned elective surgery during the course of the study.
A history of organ or hematologic transplantation, rheumatoid arthritis, or other autoimmune disorders.
Be on immunosuppressive medications.
Have a diagnosis of carcinoma with the past 2 years.
Have a knee infection or have used antibiotics for knee infection within the past 3 months.
Have participated in any other clinical trial or treatment (not just for the knee, but for any reason) with any investigational product within the past 30 days prior to inclusion of study.
Female patients who are breast feeding or are pregnant or desire to become pregnant during the course of the study.
Contraindications to radiographic or MRI imaging.
Serious neurological, psychological or psychiatric disorders.
Injury or disability claims under current litigation or pending or approved workers compensation claims.
Have a known drug allergy to amphotericin-B, ciprofloxacin, gentamycin, penicillin, or streptomycin.
  • C Reactive ProteinBaseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    C-reactive protein (CRP) is a protein made by the liver. The level of CRP increases when there's inflammation in the body. A simple blood test can check your C-reactive protein level. C-reactive protein is measured in milligrams per liter (mg/L). Results equal to or greater than 8 mg/L or 10 mg/L are considered high. Range values vary depending on the lab doing the test. A high test result is a sign of inflammation. It may be due to serious infection, injury or chronic disease. Your health care provider may recommend other tests to determine the cause.

  • Erythrocyte Sedimentation RateBaseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    Sed rate, or erythrocyte sedimentation rate (ESR), is a blood test that can show inflammatory activity in the body. Because a sed rate test can't pinpoint the problem that's causing inflammation in your body, it's often accompanied by other blood tests, such as the C-reactive protein (CRP) test. ESR is measured in millimeters per hour (mm/hr). The normal values are: 0 to 15 mm/hr in men 0 to 20 mm/hr in women

  • Alanine TransaminaseBaseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    ALT is an enzyme that converts proteins into energy for the liver cells. Aspartate transaminase (AST). AST is an enzyme that helps the body break down amino acids. Alkaline phosphatase (ALP). ALP is an enzyme important for breaking down proteins. Albumin and total protein. Albumin is a protein made in the liver. Bilirubin. Bilirubin is a substance produced during the breakdown of red blood cells. Gamma-glutamyltransferase (GGT). Higher-than-usual may mean liver damage. L-lactate dehydrogenase (LD). LD is an enzyme found in the liver. Prothrombin time (PT). PT is the time it takes your blood to clot. Standard range: Alanine transaminase (ALT). ALT is an enzyme that converts proteins into energy for the liver cells. Standard range: ALT. 7 to 55 units per liter U/L.

  • Aspartate TransaminaseBaseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    AST is an enzyme that helps the body break down amino acids. . Standard range: AST 8 to 48 units per liter

  • Alkaline PhosphataseBaseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    ALP is an enzyme important for breaking down proteins. Standard range: 40 to 129 units per liter

  • AlbuminBaseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    Albumin is a protein made in the liver. Normal range is 34 to 54 grams/liter.

  • CreatinineBaseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    Creatinine is a waste product that comes from the digestion of protein in your food and the normal breakdown of muscle tissue. It is removed from the blood through your kidneys. Everyone has some creatinine in their blood, but too much can be a sign of a possible kidney problem. Normal range is 0.6-1.3 milligrams/deciliter

  • Blood Urea NitrogenBaseline, 1 week after the procedure, 6 weeks, 3 months, 6 months and one year

    blood urea nitrogen (BUN) test reveals important information about how well your kidneys are working. A BUN test measures the amount of urea nitrogen that's in your blood. Normal BUN is 6-20 milligrams/deciliter.